Clinical Trials Browser

Phase 1 × Mesothelioma × anetumab ravtansine × Clear all

NCT02639091 2019-11-07

Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors

Phase 1 Completed

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma